Dataset Information


The 2014International Workshop on Alport Syndrome.

ABSTRACT: Alport syndrome, historically referred to as hereditary glomerulonephritis with sensorineural deafness and anterior lenticonus, is a genetic disease of collagen ?3?4?5(IV) resulting in renal failure. The collagen ?3?4?5(IV) heterotrimer forms a network that is a major component of the kidney glomerular basement membrane (GBM) and basement membranes in the cochlea and eye. Alport syndrome, estimated to affect 1 in 5000-10,000 individuals, is caused by mutations in any one of the three genes that encode the ? chain components of the collagen ?3?4?5(IV) heterotrimer: COL4A3, COL4A4, and COL4A5. Although angiotensin-converting enzyme inhibition is effective in Alport syndrome patients for slowing progression to end-stage renal disease, it is neither a cure nor an adequate long-term protector. The 2014 International Workshop on Alport Syndrome, held in Oxford, UK, from January 3-5, was organized by individuals and families living with Alport syndrome, in concert with international experts in the clinical, genetic, and basic science aspects of the disease. Stakeholders from diverse communities-patient families, physicians, geneticists, researchers, Pharma, and funding organizations-were brought together so that they could meet and learn from each other and establish strategies and collaborations for the future, with the overall aim of discovering much needed new treatments to prolong kidney function.


PROVIDER: S-EPMC4182137 | BioStudies | 2014-01-01

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5837236 | BioStudies
2020-01-01 | S-EPMC7568086 | BioStudies
2003-01-01 | S-EPMC1868284 | BioStudies
2020-01-01 | S-EPMC7210609 | BioStudies
2019-01-01 | S-EPMC6528060 | BioStudies
2019-01-01 | S-EPMC6503168 | BioStudies
2018-01-01 | S-EPMC5976824 | BioStudies
2019-01-01 | S-EPMC6391820 | BioStudies
2017-01-01 | S-EPMC5400701 | BioStudies
2017-01-01 | S-EPMC5664579 | BioStudies